TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kintor Pharmaceutical Ltd ( (HK:9939) ) has issued an update.
Kintor Pharmaceutical Limited has announced a top-up placing of existing shares and a subscription of new shares under a general mandate. The company plans to sell 20,673,000 shares at HK$2.08 per share, representing approximately 4.62% of its issued share capital. The net proceeds from this subscription, estimated at HK$40.34 million, will be used for general working capital and operations, potentially strengthening the company’s financial position and supporting its ongoing business activities.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is an investment holding company primarily engaged in the research and development of innovative medicine products and the sales of functional cosmetic products.
Average Trading Volume: 5,233,048
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.21B
For an in-depth examination of 9939 stock, go to TipRanks’ Overview page.